wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38266308-0A39345D-E6C1-4E15-9628-791E079B56E0
Q38266308-0A39345D-E6C1-4E15-9628-791E079B56E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38266308-0A39345D-E6C1-4E15-9628-791E079B56E0
Personalized treatment of EGFR mutant and ALK-positive patients in NSCLC.
P2860
Q38266308-0A39345D-E6C1-4E15-9628-791E079B56E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38266308-0A39345D-E6C1-4E15-9628-791E079B56E0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
03bd24e392e76220be3347aaecddb3d38297b33b
P2860
Clinical benefit from pemetrexed before and after crizotinib exposure and from crizotinib before and after pemetrexed exposure in patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer